TNBIOTCGrain Mill ProductsFiscal year ends December 31

Tanke Biosciences Corp

Financials through Q3 FY2013, quarter ended Sep 30, 2013Last filing: 10-Q on Nov 14, 2013

$0.03+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $399.72K
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Sep 30, 2013

Total debt

$1.87M

$1.14M due within a year

Net debt

-$3.18M

After $5.05M of cash

Implied interest rate

83.22%

FY2012 interest ÷ average debt

Interest coverage

3.1×

FY2012 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Tanke Biosciences's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Tanke Biosciences's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TNBI.

Revenue growth-19.5% · median 2.4%

Gross margin32.3% · median 31.2%

Operating margin-0.2% · median 8.9%

Net margin-7.1% · median 5.8%

Company	Revenue	Growth
GIS	$18.30B	-4.5%
POST	$8.41B	+6.2%
INGR	$7.22B	-1.4%
FRPT	$1.18B	+12.8%
TNBI	$22.96M	-19.5%
AFRI	–	–

Company

Exchange: OTC
Industry: Grain Mill Products
Fiscal year ends: December 31
Employees: 130
SEC CIK: 1452011

Advertisement
300 × 250